Business Wire

Visa Cardholders Get First Shot at Applying for FIFA World Cup 26™ Tickets

31.7.2025 13:07:00 CEST | Business Wire | Press Release

Share

It's official: the road to the FIFA World Cup 26™ starts with Visa. As the Official Payment Technology Partner of FIFA and a global leader in digital payments, Visa cardholders with a Visa Debit, Credit or reloadable Visa prepaid cards globally will receive exclusive early access to apply for tickets to the most anticipated sporting event in the world. The first-ever Visa Presale Draw was announced at the Visa Payments Vault in Washington, D.C., where government officials from Canada, Mexico and the United States gathered to celebrate trilateral collaboration and the unifying power of sport at the Visa FIFA World Cup 26™ Reception.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731190789/en/

Robert Thomson, Senior Vice President of Global Government Affairs at Visa; Eduardo Coello, Regional President for Latin America and the Caribbean at Visa; Amy Hopfinger, Chief Business and Strategy Officer for the FIFA World Cup 2026™; and Alexi Lalas, U.S. soccer legend and former national team defender, pose for a photo during the Visa FIFA World Cup 2026™ reception at the Visa Payments Vault on Wednesday, July 30, 2025 in Washington, D.C. The event celebrated the tournament’s global impact and Visa’s role as a sponsor.

“The Visa Presale Draw offers Visa cardholders exclusive early access to enter the draw for tickets, creating an incredible opportunity for some lucky fans to secure their place at this historic event,” said Kim Lawrence, Regional President of North America at Visa. “As we get closer to the tournament, Visa also plans to help communities and businesses across the continent get ready for the influx of travelers, ensuring the tournament's economic impact lasts far beyond the final whistle.”

“This is an unprecedented moment for Visa — not only are we redefining how fans experience the game, but we are also bringing them closer than ever with the opportunity to apply for exclusive ticket access through the first-ever Visa Presale Draw,” said Eduardo Coello, Regional President for Visa in Latin America and the Caribbean. “As we set new standards for safe and secure payment experiences for fans, there’s no better time to deliver on our promise than at the largest FIFA World Cup in history, right here in our region—with Mexico as a proud host.”

Empowering Fans

From September 10-19, fans with a Visa card, including Visa Credit, Visa Debit and reloadable Visa prepaid cards, can apply to enter the Visa Presale Draw – a randomized selection process that gives selected entrants the chance to purchase tickets before general ticket sales open. Interested cardholders will need a FIFA ID to participate in the Visa Presale Draw and are encouraged to visit FIFA.com/tickets today to create their ID, if they don’t already have one. Those chosen to purchase tickets through the Visa Presale Draw will be notified by email starting no earlier than September 30 and given a dedicated time slot in October to purchase available tickets on a first come, first served basis. As the official payment method for FIFA ticketing, Visa will be the exclusive payment method accepted during the presale purchase window. Learn more about the Visa Presale Draw here.

“Excitement for the FIFA World Cup 26 is building fast, and 10 September is a date every football fan should have marked in their calendar,” said FIFA Chief Business Officer Romy Gai. “We’re delighted to once again partner with Visa to give fans the very first opportunity to apply for a place at the greatest show on earth. A ticket to the FIFA World Cup™ isn’t just a ticket—it’s a gateway to the most inclusive and spectacular tournament in our history. Everyone will want to be part of this moment, so make sure you’ve created your FIFA ID and have your Visa card ready.”

Uplifting Communities and Small Businesses

As Visa cardholders from around the world apply to secure exclusive ticket access for the FIFA World Cup 2026TM, Visa also wants to help businesses get ready to make the most of the moment. By sharing trends and expertise, Visa will help empower local businesses, especially in host cities – from street vendors in Mexico City to boutiques in Kansas City, or a local bakery in Vancouver– so they can capitalize on World Cup tourism and turn tournament fanfare into lasting economic growth. More details on these programs will be shared as the match draw approaches.

A Tournament Like No Other

The FIFA World Cup 2026™ promises to be record-breaking: 48 teams, 104 matches over 39 days in 16 iconic host cities and will be the first ever tri-country hosted games across North America. With nearly 20 years of partnership with FIFA, Visa and FIFA continue to innovate and expand access for fans, business owners and communities alike.

About Visa

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250731190789/en/

Contacts

Media Contact
Allee McDermott
amcdermo@visa.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye